No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Instruments & Supplies
Well Lead Medical Co., Ltd. specializes in the comprehensive process of researching, producing, and commercializing medical catheters. These essential devices serve critical applications in various fields such as anesthesia, urology, respiratory care, and hemodialysis. The company's product portfolio also extends to drainage, suction, and nutritional delivery systems. Its offerings are integral to hospital environments, supporting surgical operations, therapeutic interventions, and both emergency and routine clinical patient management. Founded in Guangzhou, China, in 2004, the firm boasts a significant global presence, distributing its solutions across key markets including China, North America, Europe, and Japan.
www.wellead.comNo one on the platform currently holds 603309.SS.
No tracked institution reports a position in 603309.SS as of their last filing.
No one on the platform has traded 603309.SS yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 4.0% | 9.3% | 9.6% | — | — | — |
| Rev. Growth % | 8.1% | 7.6% | ||||
| Profit Margin % | 4.7% | 11.0% | 11.5% | |||
| Free Cash Flow Margin % | 7.6% | 3.9% | 4.3% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $1.8B | +6.5% | $0.91 | $0.91–$0.91 | — | 1 |
| 2027 | $2.1B | +12.8% | $1.07 | $1.07–$1.07 | — | 1 |
| 2028 | $2.4B | +13.0% | $1.28 | $1.28–$1.28 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 603309.SSWell Lead Medical Co., Ltd. | $10.63 | -0.28% | $3.1B | — |
| 300453.SZJiangxi Sanxin Medtec Co.,Ltd. | $8.95 | -1.10% | $4.7B | — |
| 300753.SZJiangsu Apon Medical Technology Co., Ltd. | $19.99 | +0.45% | $2.5B | — |
| 300871.SZHvsen Biotechnology Co., Ltd. | $21.56 | +1.13% | $4.4B | — |
| 600479.SSZhuZhou QianJin Pharmaceutical Co.,Ltd | $11.33 | -0.61% | $5.6B | — |
| 603387.SSGetein Biotech, Inc | $9.21 | +1.43% | $4.7B | — |
| 603987.SSShanghai Kindly Enterprise Development Group Co.,LTD. | $7.30 | +0.14% | $3.2B | — |
Source: Financial Modeling Prep · peers by sector/industry